MDNC — Medinotec Balance Sheet
0.000.00%
- $58.67m
- $57.08m
- $5.02m
Annual balance sheet for Medinotec, fiscal year end - February 29th, USD millions except per share, conversion factor applied.
2022 February 28th | 2023 February 28th | 2024 February 29th | |
---|---|---|---|
Period Length: | — | — | — |
Source: | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Cash | |||
Cash and Short Term Investments | 0.132 | 2.83 | 2.81 |
Net Total Accounts Receivable | |||
Net Total Receivables | 0.042 | 0.021 | 0.59 |
Total Inventory | |||
Total Other Current Assets | |||
Total Current Assets | 0.722 | 3.37 | 4.38 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 0.516 | 0.407 | 0.382 |
Long Term Notes Receivable | |||
Other Long Term Assets | |||
Total Assets | 1.32 | 4.49 | 4.8 |
Accounts Payable | |||
Payable / Accrued | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 0.209 | 0.071 | 0.827 |
Long Term Debt | |||
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Liabilities | 1.79 | 1.93 | 2.64 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | -0.47 | 2.56 | 2.17 |
Total Liabilities & Shareholders' Equity | 1.32 | 4.49 | 4.8 |
Total Common Shares Outstanding |